Cargando…
Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058386/ https://www.ncbi.nlm.nih.gov/pubmed/30062011 http://dx.doi.org/10.1186/s40248-018-0144-5 |
_version_ | 1783341683510870016 |
---|---|
author | Dal Negro, Roberto W. Bonadiman, Luca Turco, Paola |
author_facet | Dal Negro, Roberto W. Bonadiman, Luca Turco, Paola |
author_sort | Dal Negro, Roberto W. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6058386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60583862018-07-30 Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma Dal Negro, Roberto W. Bonadiman, Luca Turco, Paola Multidiscip Respir Med Correction BioMed Central 2018-07-24 /pmc/articles/PMC6058386/ /pubmed/30062011 http://dx.doi.org/10.1186/s40248-018-0144-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Correction Dal Negro, Roberto W. Bonadiman, Luca Turco, Paola Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma |
title | Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma |
title_full | Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma |
title_fullStr | Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma |
title_full_unstemmed | Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma |
title_short | Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma |
title_sort | correction to: fluticasone furoate/vilanterol 92/22 μg once-a-day vs beclomethasone dipropionate/formoterol 100/6 μg b.i.d.: a 12-month comparison of outcomes in mild-to-moderate asthma |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058386/ https://www.ncbi.nlm.nih.gov/pubmed/30062011 http://dx.doi.org/10.1186/s40248-018-0144-5 |
work_keys_str_mv | AT dalnegrorobertow correctiontofluticasonefuroatevilanterol9222mgonceadayvsbeclomethasonedipropionateformoterol1006mgbida12monthcomparisonofoutcomesinmildtomoderateasthma AT bonadimanluca correctiontofluticasonefuroatevilanterol9222mgonceadayvsbeclomethasonedipropionateformoterol1006mgbida12monthcomparisonofoutcomesinmildtomoderateasthma AT turcopaola correctiontofluticasonefuroatevilanterol9222mgonceadayvsbeclomethasonedipropionateformoterol1006mgbida12monthcomparisonofoutcomesinmildtomoderateasthma |